Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.55 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acrolein SCHEMBL157907 | 0.95 | LMNA (0.60) | LMNATRPA1ALDH1A1TSHRTHRB | |
| Acrolein SCHEMBL3930769 | 0.93 | LMNA (0.57) | LMNATRPA1ALDH1A1TSHRTHRB | |
| Butane SCHEMBL2557609 | 0.88 | LMNA (0.63) | LMNATHRB | |
| Acrolein SCHEMBL8404934 | 0.87 | LMNA (0.50) | LMNATRPA1ALDH1A1TSHR | |
| Butanedione SCHEMBL8338208 | 0.85 | LMNA (0.48) | LMNATRPA1ALDH1A1TSHR | |
| Propylene Glycol SCHEMBL9721324 | 0.84 | LMNA (0.46) | LMNATRPA1ALDH1A1TSHR | |
| 1,3-Propanediol SCHEMBL8401501 | 0.84 | LMNA (0.46) | LMNATRPA1ALDH1A1TSHR | |
| Butane SCHEMBL818136 | 0.83 | LMNA (0.63) | LMNATSHRTHRB | |
| Butadiene SCHEMBL625826 | 0.83 | LMNA (0.71) | LMNATHRB | |
| Butane SCHEMBL7994420 | 0.83 | LMNA (0.71) | LMNATHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 752 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4700051-A1 | POLYMER AND PREPARATION METHOD THEREFOR, GEL POLYMER ELECTROLYTE, BATTERY, AND ELECTRICAL DEVICE | Contemporary Amperex Technology Co., Limited (CN) | 2026-02-25 | — | — | EP | claimed |
| US-20260042882-A1 | POLYMER AND PREPARATION METHOD THEREFOR, GEL POLYMER ELECTROLYTE, BATTERY, AND ELECTRICAL DEVICE | CONTEMPORARY AMPEREX TECHNOLOGY CO LTD (CN) | 2026-02-12 | — | — | US | claimed |
| WO-2025226939-A1 | ENHANCED SENSATION CONDOM | NUCEPTIVE LABS, INC. (US) | 2025-10-30 | — | — | WO | claimed |
| US-20250320402-A1 | SYSTEMS AND METHODS FOR SCAVENGING SULFUR-CONTAINING MATERIALS USING A PRECURSOR SCAVENGER MATERIAL | CAMERON INTERNATIONAL CORPORATION | 2025-10-16 | — | — | US | claimed |
| EP-4608466-A1 | STIMULI-RESPONSIVE MEDICAL ADHESIVE COMPOSITIONS, ARTICLES, AND METHODS | Nuceptive Labs, Inc. (US) | 2025-09-03 | — | — | EP | claimed |
| EP-4608465-A1 | ENHANCED SENSATION CONDOM | Nuceptive Labs, Inc. (US) | 2025-09-03 | — | — | EP | claimed |
| CN-119775203-A | Synthesis method of carbamazepine intermediate 6- (3, 3-diethoxypropyl) quinoline | 河北科技大学 | 2025-04-08 | — | — | CN | claimed |
| WO-2024221838-A1 | POLYMER AND PREPARATION METHOD THEREFOR, GEL POLYMER ELECTROLYTE, BATTERY, AND ELECTRICAL DEVICE | 宁德时代新能源科技股份有限公司 | 2024-10-31 | — | — | WO | claimed |
| CN-118852507-A | Polymer, preparation method thereof, gel polymer electrolyte, battery and electricity utilization device | 宁德时代新能源科技股份有限公司 | 2024-10-29 | — | — | CN | claimed |
| US-20240246916-A1 | 7-NITRO-8-HYDROXYQUINOLINE DERIVATIVES, PREPARATION METHOD THEREFORE AND MEDICAL USE THEREOF | JIANGSU YAHONG MEDITECH CO., LTD. (CN) | 2024-07-25 | — | — | US | claimed |
| US-4851583-A | Method of generating acrolein | BETZ LABORATORIES, INC. (US) | 1989-07-25 | — | — | US | claimed |
| EP-0311619-A1 | CHELATE LIGANDS FOR LOW PRESSURE HYDROFORMYLATION CATALYST AND PROCESS EMPLOYING SAME. | EASTMAN KODAK CO (US) | 1989-04-19 | — | — | EP | claimed |
| US-4774362-A | HYDROFORMYLATION CATALYSTS FOR REACTION OF OLEFINS | EASTMANK KODAK COMPANY (US) | 1988-09-27 | — | — | US | claimed |
| EP-0279018-A1 | Chelate ligands for low pressure hydroformylation catalyst and process employing same | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1988-08-24 | — | — | EP | claimed |
| US-4760194-A | Hydroformylation, reacting olefin with carbon monoxide and hydrogen in presence of rhodium complex catalyst | EASTMAN KODAK COMPANY (US) | 1988-07-26 | — | — | US | claimed |
| US-4755624-A | Low pressure hydroformylation process | EASTMAN KODAK COMPANY (US) | 1988-07-05 | — | — | US | claimed |
| WO-1987007600-A2 | CHELATE LIGANDS FOR LOW PRESSURE HYDROFORMYLATION CATALYST AND PROCESS EMPLOYING SAME | EASTMAN KODAK COMPANY (US) | 1987-12-17 | — | — | WO | claimed |
| US-4694109-A | Chelate ligands for low pressure hydroformylation catalyst and process employing same | EASTMAN KODAK COMPANY (US) | 1987-09-15 | — | — | US | claimed |
| US-4476033-A | ACRYLAMIDE POLYMER , POLYMER, ACID, ALDEHYDE PRECURSOR WHICH HYDROLYZES TO REACT WITH POLYMER | PHILLIPS PETROLEUM COMPANY (US) | 1984-10-09 | — | — | US | claimed |
| EP-0100071-A2 | Method and compositions for acidizing and fracturing wells | PHILLIPS PETROLEUM COMPANY (US) | 1984-02-08 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260042882-A1 | POLYMER AND PREPARATION METHOD THEREFOR, GEL POLYMER ELECTROLYTE, BATTERY, AND ELECTRICAL DEVICE | SLC8A1, SLC9A1, F8 | LMNA 1234/4885TRPA1 3551/4885ALDH1A1 633/4885 |
| US-20240246916-A1 | 7-NITRO-8-HYDROXYQUINOLINE DERIVATIVES, PREPARATION METHOD THEREFORE AND MEDICAL USE THEREOF | CYP3A7, UGT1A7, UGT2B7 | LMNA 2723/4885TRPA1 4479/4885ALDH1A1 1017/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.